Article News

VECTRA® H2 Featured in Face and Body Germany Magazine

In the September 2022 issue of Face and Body Germany, Prof. Dr. med. Dimitra Kotsougiani-Fischer of AESTHETIKON in Mannheim and Heidelberg Germany discusses how the VECTRA H2 enables detailed preoperative documentation and quantifies volume defects quickly and easily.

Canfield Sponsors the Mission to Raise $250,000 for Melanoma Research

Last week, ten doctors broke the Guinness World Record for the fastest time to row one million meters and raised around $245,000 for melanoma and skin cancer research at the University of Queensland Dermatology Research Centre. The endurance rowing challenge to break the record for the fastest team to row one million meters was in honor of team leader, Dr Chris Conyard’s sister-in-law, Phoebe Eales, who passed away at 31 as a result of melanoma.

FaceReality Awarded 3rd place in IMCAS 2022 Innovation of the Year Competition

In June, FaceReality, an AI driven module within Canfield’s Mirror® for iPad® app, was awarded 3rd place in the IMCAS Innovation of the Year competition series. The series highlights the latest advances in the fields of dermatology, plastic surgery, skincare, and aesthetic science.

Canfield's Mirror® Mobile App for iPad and New FaceReality Module Featured in MedEsthetics Magazine

Canfield’s Mirror mobile app for iPad was featured recently in the January and February edition of MedEsthetics magazine. Both the Mirror Mobile app and it's new AI-driven module, FaceReality, was included in a list of strategies that can improve patient satisfaction from first encounters to follow-up care. Mirror Mobile app with FaceReality allows physicians to simulate outcomes based on the patient’s desire to improve their first impression, (whether it be healthier, competent, or well-rested) through surgical and non-surgical procedures. 

Canfield’s VECTRA® WB360, VISIA® provide doctors with advanced technology to assess and educate their patients on the effects of prolonged sun exposure

Cutting edge technology is making whole body screening easier than ever for both doctors and patients. Canfield's VECTRA® WB360 3D whole-body imaging system provides doctors with the technology to examine their patients efficiently for signs of sun damage, reducing unnecessary biopsies and procedures.  Dr. Steven Q. Wang, director of Dermatologic Surgery and Dermatology at Memorial Sloan Kettering Cancer Center shared, “the benefit to the patient is you don’t have to get all those benign lesions taken out.”

Canfield’s VECTRA WB360® uses advanced 3D-body mapping technology with A.I. to assist Baptist Health doctors with melanoma screenings

Canfield’s VECTRA WB360® provides doctors at Baptist Health in Miami advanced body mapping technology as they monitor patients. The advanced imaging system includes 92 cameras flashing simultaneously, with cross-polarized and polarized lighting to reveal all skin features. Naiara Braghiroli, MD, PHD, explains that with the VECTRA’s advanced body mapping technology, doctors at Baptist Health can create a 3D avatar of their patient, and “can navigate every single lesion and every part of the skin”.  

VECTRA® 3D Imaging Used in Experimental Study to Measure the Effects of Injectables and Facial Fillers

Canfield’s VECTRA 3D imaging system has been used to assist researchers as they conducted an experimental study focused on the effects of injectables and facial fillers. The study suggested that dermal fillers’ “volumizing” effects may also lead to subsequent “lifting effects”, as it suggests that lateral facial injections co-influence adjacent lateral facial regions. Sebastian Cotofana, MD, PhD and his team at the Mayo Clinic in Rochester, Minnesota measured the effects of the injections on specially prepared specimens by using VECTRA 3D imaging. The before-and-after scans from the VECTRA system showed that the dermal fillers led to significant increases in local soft tissue volume and local lifting effects on central facial injection areas, including “up to one millimeter of vertical ‘lift’ in the forehead area”.

 Canfield’s VECTRA® WB180 is a “game-changer”, per Mount Sinai Hospital

Doctors at Mount Sinai’s Waldman Melanoma Center use Canfield’s VECTRA® WB180 3D whole-body imaging system to screen patients as they spread awareness during Melanoma May. Canfield’s VECTRA WB180 imaging system captures 3D bodymap images with non-polarized and cross-polarized lighting for an enhanced view of lesions on the surface of the skin. The high-quality standardized images allow doctors at the Waldman Center to identify and track suspicious lesions. Richard Torbek of Mount Sinai’s Icahn’s School of Medicine cites the VECTRA WB180 as a “game-changer” as the system assists Mount Sinai’s doctors in prevention and detection. 

VECTRA® WB180 provides 3D whole-body imaging at Mount Sinai’s new Melanoma and Skin Cancer Center.

Canfield’s VECTRA® WB180 has been introduced at Mount Sinai Hospital as part of a larger initiative by the dermatology department to establish a new Melanoma and Skin Cancer Center. The whole-body imaging system uses 3D-body mapping technology to track pigmented lesions on the skin’s surface. The VECTRA WB180 will assist Mount Sinai’s staff and highly trained specialists with providing patients the highest quality of care. In addition,  Mount Sinai’s researchers will be using the VECTRA WB180 alongside other advanced technologies to explore new skin cancer therapies and research approaches.

VISIA® Featured in ELLE Germany Magazine

In the latest April 2021 issue of ELLE Germany, Beauty Editor Sarah Vogelsang discusses how VISIA Skin Analysis helps her get to know her skin better. She reviews the extensive functions and analysis tools VISIA has to offer, and talks about how impressive the results are.